Back
Omnicell, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
64
OMCL
Omnicell, Inc.
Last Price:
$45.58
Seasonality Move:
-2.58%
Buy
61
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
64
Omnicell, Inc. (OMCL)
is a Buy
Is Omnicell, Inc. a Buy, Sell or Hold?
-
The current Omnicell, Inc. [OMCL] share price is $45.57. The Score for OMCL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
OMCL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.33. The Score for LYEL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OMCL Stock Price Chart
What is Omnicell, Inc.'s stock price today?
-
The Omnicell, Inc. share price today is $45.57The current trend is moderately bullish and OMCL is experiencing slight buying pressure.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
OMCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.8 | Buy |
| Relative Strength Index (14 RSI): | 70.73 | Buy |
| Chaikin Money Flow: | 169036 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.47 - 44.91) | Buy |
| Bollinger Bands (100): | (29.54 - 38.76) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.24 | Buy |
| Relative Strength Index (14 RSI): | 78.97 | Buy |
| Chaikin Money Flow: | -246560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.8 - 33.24) | Buy |
| Bollinger Bands (100): | (10.76 - 24.28) | Buy |
OMCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.25 | Buy |
| 20-day SMA: | 42.08 | Buy |
| 50-day SMA: | 36.77 | Buy |
| 200-day SMA: | 32.23 | Buy |
| 8-day EMA: | 45.1 | Buy |
| 20-day EMA: | 42.53 | Buy |
| 50-day EMA: | 38.43 | Buy |
| 200-day EMA: | 34.77 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34 | Buy |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 22.08 | Buy |
| 200-day SMA: | 13.64 | Buy |
| 8-day EMA: | 33.98 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 23.99 | Buy |
| 200-day EMA: | 17.62 | Buy |
Omnicell, Inc. Earnings Growth & OMCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.13 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Omnicell, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||